HYBRID, Greater New York City Area, United States of America
Job Type


Sr. Clinical Study Manager | (Ph. II/III Lead) | $1Bn+ EU Pharma setting up first US office in New York City | Hybrid | RETAINED SEARCH

Cornerstone Search Group has been retained by a $1Bn+ (revenue) European pharmaceutical company focused in Oncology and CNS that is setting up their first hub in the USA in New York City. This newly-created, versatile, and hybrid Senior Clinical Study Manager (CSM) position will be leading clinical operations for a high-profile neuroscience asset (potential first-in-class) from Phase II through NDA, working directly with the MD leading the program. Our client is a well-established and financially stable company with a very positive culture. This is an exciting (and rare) opportunity to help establish a successful European company’s footprint in the US from scratch.

COMPENSATION: Highly competitive compensation


New York City (hybrid)

Our client will consider candidates who prefer a hybrid work arrangement that would only require working on-site on a limited basis.


(1) This company takes a lot of pride in its culture, reflecting its country’s heritage as having one of the world’s most positive cultures.

(2) You will work closely with the clinical leadership of this company on the asset as well as on establishing this company’s presence in the US.

(3) Our client has a portfolio of Oncology and CNS pipeline assets and a successful history of discovering and developing many Oncology and CNS marketed drugs.

(4) Our company is comfortable with a hybrid and flexible work arrangement.


As a Senior Clinical Study Manager, you will be accountable for the operational oversight of  clinical trials, starting with being the lead on a high-profile, potential first-in-class, neuroscience asset entering Phase II in multiple arms. The goal is for this Sr. CSM to lead this asset through Phase III and NDA. The scope includes trial start-up, conduct, and close-out activities as well as training and overseeing the CRO (which will be monitoring these trials) and other clinical service providers.

Desired Skills / Qualifications / Experience / Behaviors:

  • BA/BS required. Master’s is a plus.
  • 5+ years of relevant experience for a pharma or CRO. Experience with a biotech or smaller pharma is a plus.
  • Seeking experience with developing trial plans including oversight plans, site monitoring plans, pharmacy and lab manuals, risk mitigation strategies, and trial budgets.
  • Working knowledge of MS Project or similar project management tool.
  • Experience within, or managing of, a CRO is a plus.
  • CNS /Psychiatric / Pain experience and/or Immunology / Inflammation and/or Acute Care / Hospital and/or Oncology (their other major TA is Oncology) is a plus, but not required.
  • Strong written and verbal communication skills.
  • Seeking a proactive, self-motivated, and entrepreneurial individual who is transparent, flexible, builds trusting relationships, is highly collaborative, and values being part of and contributing to a company that is very culture-focused.


Corey Ackerman
Corey S. Ackerman, JD Email: cackerman@cornerstonesg.com Phone: 973-656-0220x716 LinkedIn: http://www.linkedin.com/in/coreyackerman
Cornerstone Search Group, LLC
350 Main Street | Chatham, New Jersey 07928, USA

Recently Completed Retained Searches by Cornerstone

  • CEO | specialty pharma start-up
  • CEO | regenerative medicine start-up
  • US CEO | established European small pharma
  • President/US Commercial Head | generics pharma
  • CMO | late-stage public biotech
  • CMO | mid-size pharma
  • CSO | mid-size global biotech
  • SVP, Head of Global Medical Affairs | mid-size oncology company
  • SVP, Head of Global Clinical Development | multi-TA mid-size pharma
  • SVP, Head of Global Regulatory Affairs | late-stage Israeli biotech
  • Group VP, Global Commercial Head | API Business Unit | Indian pharma
  • VP, Data Science RWE | Top 5 Pharma
  • VP, Head of Regulatory Affairs | Boston biotech
  • VP, US Head of Regulatory Affairs | Top 20 Pharma
  • VP, Head of R&D Operations | Boston biotech
  • VP, Head of HEOR (Health Economics & Outcomes Research | Top CNS specialty pharma
  • VP, Head of US HEOR & RWE | Top 5 Pharma
  • VP, Head of Real-World Evidence | Top 5 pharma
  • VP, Head of US HEOR | Top Oncology Pharma
  • ED, Head of HEOR | Top West Coast Pharma
  • VP, Head of Global Market Access | Top Oncology Specialty Pharma
  • VP, Head of US Market Access | High-profile late stage biotech
  • VP, Head of US Market Access | West Coast Late-Stage Public Biotech
  • VP, Head of Heme/Onc Clinical Research | Public oncology biotech
  • VP, Head of Clinical Development | late-stage anti-infectives UK pharma
  • VP, Head of Global Drug Safety & PV | Chinese oncology biotech
  • ED, Head of Clinical Operations | British VC-backed biotech
  • ED, Global Commercial Strategy Franchise Head | Top rare disease Boston pharma
  • ED, Head of Global Clinical Pharmacology | Public oncology biotech
  • ED, Head of Global HEOR | Large US Pharma
  • Head, Patient Advocacy | European commercial-stage rare disease biotech
  • Medical Directors (Director/SD/ED levels) in Translational Medicine / Clinical Development / Medical Affairs / Drug Safety: 75+ retained assignments
  • HEOR/RWE/Market Access (AD/Director/SD/ED levels): 100+ retained assignments

Cornerstone's Privacy Policy

Cornerstone Search Group considers all inquiries, resume submissions, and any other personal information submitted to us as confidential information. This information will not be shared with any parties outside of Cornerstone Search Group without your prior permission.

Apply for Sr. Clinical Study Manager
Drop files here browse files ...
Back To Featured Searches List
Are you sure you want to delete this file?